Knowledge Tree
Relations (1)
cross_type 0.50 — strongly supporting 5 facts
The United States Food and Drug Administration regulates artificial intelligence in healthcare by classifying AI-based diagnostic tools as Software as a Medical Device [1] and establishing oversight frameworks for AI/ML-enabled medical devices {fact:2, fact:3, fact:5}. Furthermore, the agency provides guidelines that define the role of AI as an augmentative tool in clinical settings [2].
Facts (5)
Sources
Medical Hallucination in Foundation Models and Their ... medrxiv.org 4 facts
claimThe Food and Drug Administration (FDA) classifies AI systems intended for the diagnosis, treatment, or prevention of disease as Software as a Medical Device (SaMD).
claimThe U.S. Food and Drug Administration (FDA) has introduced new approaches to change control for AI/ML-enabled medical devices to allow for more flexible oversight of systems that continue to learn and evolve after deployment.
referenceThe FDA published Good Machine Learning Practice (GMLP) guidance to address challenges in AI/ML-enabled medical devices, specifically covering data quality, algorithm validation, and performance monitoring.
claimFDA adaptations for AI/ML-enabled medical devices primarily address supervised learning systems rather than the unique challenges posed by generative AI.
Medical Hallucination in Foundation Models and Their Impact on ... medrxiv.org 1 fact
claimThe Food and Drug Administration (FDA) guidelines position AI systems as augmentative tools rather than replacements for clinical judgment, asserting that healthcare providers must retain ultimate responsibility for medical decisions.